Form 4: TriSalus Life Sciences Executive Receives Stock and Option Awards

Richard Marshak, Chief Commercial Officer of TriSalus Life Sciences, receives restricted stock units and stock options.

Summary

• Richard Marshak, Chief Commercial Officer of TriSalus Life Sciences, received 12,500 shares of common stock in the form of restricted stock units (RSUs) and options to purchase 75,000 shares of common stock on January 27, 2025.
• The RSUs vest in four equal annual installments starting January 1, 2025, contingent upon continued service with the Issuer.
• The stock options have an exercise price of $5.30 and vest over time, with one-fourth vesting on January 1, 2025, and the remainder vesting monthly thereafter, also contingent upon continued service.
• Following these transactions, Marshak directly owns 46,626 shares of common stock and options to purchase 75,000 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The grant of RSUs and stock options to the Chief Commercial Officer aligns his interests with those of the shareholders.
• The vesting schedules for both the RSUs and stock options incentivize continued service with the company.

Risks

• The value of the RSUs and stock options is dependent on the future performance of TriSalus Life Sciences' stock.
• If Marshak leaves the company before the RSUs and stock options fully vest, he will forfeit the unvested portion.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the equity awards.

Industry Context

Equity grants are a common practice in the life sciences industry to attract and retain key personnel, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Equity compensation packages for C-level executives in biotech companies typically include a mix of stock options and restricted stock units.
• The vesting schedules described are fairly standard, designed to incentivize long-term commitment.
• The specific amounts of equity granted would be benchmarked against peer companies of similar size and stage of development.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning management's interests with the company's long-term success.
• Employees may be motivated by the potential for future equity grants.

Key Dates